Sodium channel SCN1A and epilepsy: mutations and mechanisms
- PMID: 20831750
- PMCID: PMC2937162
- DOI: 10.1111/j.1528-1167.2010.02640.x
Sodium channel SCN1A and epilepsy: mutations and mechanisms
Abstract
Mutations in a number of genes encoding voltage-gated sodium channels cause a variety of epilepsy syndromes in humans, including genetic (generalized) epilepsy with febrile seizures plus (GEFS+) and Dravet syndrome (DS, severe myoclonic epilepsy of infancy). Most of these mutations are in the SCN1A gene, and all are dominantly inherited. Most of the mutations that cause DS result in loss of function, whereas all of the known mutations that cause GEFS+ are missense, presumably altering channel activity. Family members with the same GEFS+ mutation often display a wide range of seizure types and severities, and at least part of this variability likely results from variation in other genes. Many different biophysical effects of SCN1A-GEFS+ mutations have been observed in heterologous expression systems, consistent with both gain and loss of channel activity. However, results from mouse models suggest that the primary effect of both GEFS+ and DS mutations is to decrease the activity of GABAergic inhibitory neurons. Decreased activity of the inhibitory circuitry is thus likely to be a major factor contributing to seizure generation in patients with GEFS+ and DS, and may be a general consequence of SCN1A mutations.
Keywords: Dravet syndrome; GEFS; Genetics; Knock-in mice; Knockout mice.
Figures

Similar articles
-
Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus.Neurobiol Dis. 2011 Mar;41(3):655-60. doi: 10.1016/j.nbd.2010.11.016. Epub 2010 Dec 13. Neurobiol Dis. 2011. PMID: 21156207 Free PMC article.
-
Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus?Brain Dev. 2009 May;31(5):394-400. doi: 10.1016/j.braindev.2009.01.001. Epub 2009 Feb 8. Brain Dev. 2009. PMID: 19203856 Review.
-
Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities.Epilepsia. 2007 Sep;48(9):1678-1685. doi: 10.1111/j.1528-1167.2007.01122.x. Epub 2007 Jun 11. Epilepsia. 2007. PMID: 17561957
-
[Phenotype and SCN1A gene mutation screening in 39 families with generalized epilepsy with febrile seizures plus].Zhonghua Er Ke Za Zhi. 2012 Aug;50(8):580-6. Zhonghua Er Ke Za Zhi. 2012. PMID: 23158734 Chinese.
-
Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity.Neurology. 2004 Jul 27;63(2):329-34. doi: 10.1212/01.wnl.0000129829.31179.5b. Neurology. 2004. PMID: 15277629 Review.
Cited by
-
Voltage Gated Sodium Channel Genes in Epilepsy: Mutations, Functional Studies, and Treatment Dimensions.Front Neurol. 2021 Mar 24;12:600050. doi: 10.3389/fneur.2021.600050. eCollection 2021. Front Neurol. 2021. PMID: 33841294 Free PMC article. Review.
-
Role of Sodium Channels in Epilepsy.Cold Spring Harb Perspect Med. 2016 Jun 1;6(6):a022814. doi: 10.1101/cshperspect.a022814. Cold Spring Harb Perspect Med. 2016. PMID: 27143702 Free PMC article. Review.
-
Deciphering the Complexities of Sodium Voltage-Gated Channel Alpha Subunit 1 (SCN1A) Mutation: A Case of Intractable Epilepsy in a Five-and-a-Half-Month-Old Male.Cureus. 2024 Jul 9;16(7):e64171. doi: 10.7759/cureus.64171. eCollection 2024 Jul. Cureus. 2024. PMID: 39119390 Free PMC article.
-
Pathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: A view from preclinical studies.Neurobiol Dis. 2015 Jul;79:135-49. doi: 10.1016/j.nbd.2015.04.015. Epub 2015 May 9. Neurobiol Dis. 2015. PMID: 25968935 Free PMC article. Review.
-
Targeted Molecular Strategies for Genetic Neurodevelopmental Disorders: Emerging Lessons from Dravet Syndrome.Neuroscientist. 2023 Dec;29(6):732-750. doi: 10.1177/10738584221088244. Epub 2022 Apr 13. Neuroscientist. 2023. PMID: 35414300 Free PMC article. Review.
References
-
- Alekov AK, Rahman M, Mitrovic N, Lehmann-Horn F, Lerche H. Enhanced inactivation and acceleration of activation of the sodium channel associated with epilepsy in man. Eur J Neurosci. 2001;13:2171–2176. - PubMed
-
- Baulac S, Huberfeld G, Gourfinkel-An I, Mitropoulou G, Beranger A, Prud’homme J-F, Baulac M, Brice A, Bruzzone R, LeGuern E. First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the γ2-subunit gene. Nat Genet. 2001;28:46–48. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases